Investigation on the Effect of Smoking on the Expression of Pro- and Anti-thrombotic, Anti-oxidative, and Inflammatory Markers in Humans

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02198937

Enrollment

Registered

2014-07-24

Start date

2014-06-30

Completion date

2016-03-31

Last updated

2016-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Smoking, Thrombosis

Keywords

smokers, non-smokers

Brief summary

Investigation on the effect of smoking on thrombus formation in humans. The expression of pro- and anti-thrombotic, anti-oxidative, and inflammatory markers will be assessed in 25-50 year old healthy smokers and non-smokers. The investigators are interested in possible differences between the two groups.

Interventions

OTHERBlood sample

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

25 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Smoker * Non-smokers

Exclusion criteria

* Disease * Pregnancy

Design outcomes

Primary

Measure	Time frame
Expression of pro- and anti-thrombotic, anti-oxidative, and inflammatory markers in blood	Single time point, no follow-up (cross sectional)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026